Global Sleep Apnea Devices Market valued at $5.5 billion in 2021, is set to witness a decent growth of 7% by 2026
Obstructive sleep apnea (OSA) is the most common form of sleep-disordered breathing (SDB). It is a partial or complete collapse of the upper airway caused by the relaxation of the muscles controlling the soft palate and tongue. The prevalence of OSA has been increasing steadily, and as per estimates, it affects ~3% to 20% of the general population. Technological Innovations is driving the Sleep Apnea Devices Market Growth The global sleep apnea devices market is a technology-driven market and is marked by constant product enhancements and market innovations. For instance, In October, 2021, AirAvant Medical introduced a new device called Bongo Rx for the treatment of obstructive sleep apnea (OSA). The device is touted as continuous positive airway pressure (CPAP) alternative and is clinically proven to treat mild to moderate OSA symptoms. In August 2021, Resmed , launched AirSense 11, the company’s next-generation PAP (positive airway pressure) device. AirSense 11 includes new feat...